المؤلفون: Singh, D., Boguş, M., Moskalenko, V., Noi, A.

المصدر: European Respiratory Journal 0-0

مصطلحات موضوعية: MeSH Administration, inhalation, COVID-19, Humans, Janus Kinase Inhibitors, Janus Kinases, SARS-CoV-2 EMTREE drug terms advanced glycation end product receptor, C reactive protein, dexamethasone, heparin, nezulcitinib, placebo, remdesivir, Janus kinase, Janus kinase inhibitor EMTREE medical terms adult, arterial oxygen saturation, clinical article, controlled study, coronavirus disease 2019, double blind procedure, drug dose escalation, drug dose increase, drug safety, drug tolerability, drug withdrawal, female, fraction of inspired oxygen, human, hypertransaminasemia, invasive ventilation

وصف الملف: application/pdf

Relation: https://ibn.idsi.md/vizualizare_articol/185071; urn:issn:09031936

الاتاحة: https://ibn.idsi.md/vizualizare_articol/185071
https://doi.org/10.1183/13993003.00673-2021